IA
Insight Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503K | Buy |
59,675
+19,319
| +48% | +$163K | 0.08% | 154 |
|
|
2025
Q1 | $321K | Buy |
40,356
+11,164
| +38% | +$88.8K | 0.06% | 197 |
|
|
2024
Q4 | $282K | Buy |
29,192
+4,942
| +20% | +$47.8K | 0.05% | 228 |
|
|
2024
Q3 | $273K | Buy |
24,250
+3,073
| +15% | +$34.6K | 0.05% | 240 |
|
|
2024
Q2 | $221K | Buy |
21,177
+7,861
| +59% | +$82.1K | 0.04% | 265 |
|
|
2024
Q1 | $152K | Buy |
+13,316
| New | +$152K | 0.03% | 284 |
|
|
2023
Q2 | – | Sell |
-21,428
| Closed | -$264K | – | 298 |
|
|
2023
Q1 | $264K | Sell |
21,428
-4,050
| -16% | -$49.9K | 0.06% | 243 |
|
|
2022
Q4 | $319K | Sell |
25,478
-5,570
| -18% | -$69.7K | 0.11% | 230 |
|
|
2022
Q3 | $390K | Sell |
31,048
-627
| -2% | -$7.88K | 0.15% | 175 |
|
|
2022
Q2 | $486K | Buy |
31,675
+1,655
| +6% | +$25.4K | 0.16% | 156 |
|
|
2022
Q1 | $451K | Buy |
30,020
+5,435
| +22% | +$81.7K | 0.14% | 190 |
|
|
2021
Q4 | $488K | Buy |
+24,585
| New | +$488K | 0.14% | 173 |
|